These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 33613232)

  • 1. Vitiligo-Like Depigmentation following Treatment with Imiquimod 5% Cream for Condylomata Acuminata.
    Alatabani M; Ghobara Y; Alissa A
    Case Rep Dermatol; 2021; 13(1):36-41. PubMed ID: 33613232
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vulvar vitiligo-like depigmentation and multiple halos of hypomelanosis at the trunk following treatment with imiquimod 5% cream for vulvar condylomata: casual or related events?
    Serra MC; Menicanti C; Pennacchioli E; Tosti G
    An Bras Dermatol; 2014; 89(5):806-7. PubMed ID: 25184923
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induction of vitiligo after imiquimod treatment of condylomata acuminata.
    Li W; Xin H; Ge L; Song H; Cao W
    BMC Infect Dis; 2014 Jun; 14():329. PubMed ID: 24928346
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Self-administered topical 5% imiquimod cream for external anogenital warts. HPV Study Group. Human PapillomaVirus.
    Edwards L; Ferenczy A; Eron L; Baker D; Owens ML; Fox TL; Hougham AJ; Schmitt KA
    Arch Dermatol; 1998 Jan; 134(1):25-30. PubMed ID: 9449906
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Topical imiquimod: a review of its use in genital warts.
    Perry CM; Lamb HM
    Drugs; 1999 Aug; 58(2):375-90. PubMed ID: 10473026
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Possible mechanisms in the induction of vitiligo-like hypopigmentation by topical imiquimod.
    Mashiah J; Brenner S
    Clin Exp Dermatol; 2008 Jan; 33(1):74-6. PubMed ID: 17979992
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of genital warts with an immune-response modifier (imiquimod).
    Beutner KR; Spruance SL; Hougham AJ; Fox TL; Owens ML; Douglas JM
    J Am Acad Dermatol; 1998 Feb; 38(2 Pt 1):230-9. PubMed ID: 9486679
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of Vitiligo-Like Depigmentation after Treatment of Lentigo Maligna Melanoma with 5% Imiquimod Cream.
    Kim NH; Lee JB; Yun SJ
    Ann Dermatol; 2018 Aug; 30(4):454-457. PubMed ID: 30065586
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhanced bleaching treatment: opportunities for immune-assisted melanocyte suicide in vitiligo.
    Webb KC; Eby JM; Hariharan V; Hernandez C; Luiten RM; Le Poole IC
    Exp Dermatol; 2014 Aug; 23(8):529-33. PubMed ID: 24840876
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Condylomata acuminata in the neovagina after male-to-female reassignment treated with CO2 laser and imiquimod.
    Matsuki S; Kusatake K; Hein KZ; Anraku K; Morita E
    Int J STD AIDS; 2015 Jun; 26(7):509-11. PubMed ID: 24970474
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of external genital warts in men using 5% imiquimod cream applied three times a week, once daily, twice daily, or three times a day.
    Fife KH; Ferenczy A; Douglas JM; Brown DR; Smith M; Owens ML;
    Sex Transm Dis; 2001 Apr; 28(4):226-31. PubMed ID: 11318254
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genital vitiligo-like depigmentation following use of imiquimod 5% cream.
    Serrão VV; Páris FR; Feio AB
    Eur J Dermatol; 2008; 18(3):342-3. PubMed ID: 18474469
    [No Abstract]   [Full Text] [Related]  

  • 13. Imiquimod, a patient-applied immune-response modifier for treatment of external genital warts.
    Beutner KR; Tyring SK; Trofatter KF; Douglas JM; Spruance S; Owens ML; Fox TL; Hougham AJ; Schmitt KA
    Antimicrob Agents Chemother; 1998 Apr; 42(4):789-94. PubMed ID: 9559784
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vitiligo-like depigmentation induced by imiquimod treatment of superficial basal cell carcinoma.
    Sriprakash K; Godbolt A
    Australas J Dermatol; 2009 Aug; 50(3):211-3. PubMed ID: 19659986
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Topical imiquimod 5% cream as an effective treatment for external genital and perianal warts in different patient populations.
    Sauder DN; Skinner RB; Fox TL; Owens ML
    Sex Transm Dis; 2003 Feb; 30(2):124-8. PubMed ID: 12567169
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genital vitiligo following use of imiquimod 5% cream.
    Zhang R; Zhu W
    Indian J Dermatol; 2011 May; 56(3):335-6. PubMed ID: 21772604
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Imiquimod 5% cream for external genital or perianal warts in human immunodeficiency virus-positive patients treated with highly active antiretroviral therapy: an open-label, noncomparative study.
    Saiag P; Bauhofer A; Bouscarat F; Aquilina C; Ortonne JP; Dupin N; Mougin C
    Br J Dermatol; 2009 Oct; 161(4):904-9. PubMed ID: 19466962
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Imiquimod 5% cream in the treatment of anogenital warts in female patients.
    Buck HW; Fortier M; Knudsen J; Paavonen J
    Int J Gynaecol Obstet; 2002 Jun; 77(3):231-8. PubMed ID: 12065134
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics of daily self-application of imiquimod 3.75% cream in adult patients with external anogenital warts.
    Wu J; Feldman R; Barry GT; Kulp J; Adams MP; Levy S
    J Clin Pharmacol; 2012 Jun; 52(6):828-36. PubMed ID: 22232733
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Imiquimod 5% cream is an acceptable treatment option for external anogenital warts in uncircumcised males.
    Maw RD; Kinghorn GR; Bowman CA; Goh BT; Nayagam AT; Nathan M
    J Eur Acad Dermatol Venereol; 2002 Jan; 16(1):58-62. PubMed ID: 11952292
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.